MCAM and breast neoplasm: We further show that down-modulation or over-expression of CD146 are associated with opposite changes in JAM-A expression, in heregulin responses and increased resistance to chemotherapy suggesting that poor prognosis of CD146 positive breast tumors is related to CD146-induced EMT and increased resistance to chemotherapy.